Epic Sciences Appoints Toni Wayne as Vice President of Human Resources

Print 13 November 2014

Strategic leader in aligning human resources management with business objectives and operations joins Epic's fast-paced, rapid-growth team.

SAN DIEGO, Nov. 13, 2014 /PRNewswire/ -- Epic Sciences announced today the appointment of Toni Wayne as vice president of human resources. Ms. Wayne has more than 20 years of experience as a senior level human resources executive in diverse life sciences companies. At Epic, Ms. Wayne will develop best-of-class strategies and processes that facilitate Epic's continued growth including organizational development, recruitment, training and talent management. From the accurate and rapid enumeration and characterization of circulating tumor cells (CTCs), Epic is developing new ways to deliver insights into disease status and therapeutic response of a patient's cancer across each clinical decision point.

"Toni is an exceptional organizational leader who guides companies during periods of rapid growth by architecting human resources strategies that maximize and align employees' talents and potential with core business goals and objectives," said Murali Prahalad, Ph.D., president and CEO of Epic Sciences. "I look forward to working with Toni as we continue to build a great team focused on delivering actionable, real-time information to better fight cancer."

"The team at Epic Sciences is amazing, and I have been impressed with their passion, talent and commitment to fighting cancer," said Ms. Wayne. "I am excited to join the Epic team and help further develop and grow the high-performance culture to achieve Epic's goal of making significant advancements in cancer diagnosis to better target treatments and improve patient outcomes."

Prior to joining Epic Sciences, Toni Wayne was vice president of Human Resources at Prometheus Laboratories, where she was a member of the executive team, leading human resources strategic planning and talent management. In 2010 she was honored as a San Diego Human Resources Professional of the Year for mid-sized companies. Prior to Prometheus, she held the position of vice president of Human Resources for Baxter Healthcare's BioScience division, where she directed Human Resources for the division's North American operations, and, ultimately, for the division's global Research and Development and Commercial Operations. Ms. Wayne also was vice president of Human Resources for Elan's Biopharmaceutical division. She started her career in biotech with Hybritech Incorporated, where she held varying positions of management responsibility in Human Resources, Manufacturing, Quality and Project Management. Ms. Wayne is also a board member of the San Diego Biotech Employment Development Coalition. 

About Epic Sciences

Epic Sciences, Inc. is developing novel diagnostics to personalize and advance the treatment and management of cancer. Epic's mission is to enable the rapid and non-invasive detection of genetic and molecular changes in cancer throughout a patient's journey. The company was founded on a powerful platform to identify and characterize rare cells, including circulating tumor cells (CTCs). Our technology will help match patients to targeted therapies and monitor for drug resistance, so that the best treatment path can be chosen or modified at every clinical decision point. Today, we partner with leading pharmaceutical companies and major cancer centers around the world. Epic's goal is to commercialize our technology to increase the success rate of cancer drugs in clinical trials and improve patient outcomes by providing physicians real-time information to guide treatment choices.

Return

All Partners

All Portfolio

MEDIA CENTER

  • NovaMedica began construction of a pharmaceutical plant in the Kaluga region

    NovaMedica began construction of a pharmaceutical plant in the Kaluga region

    Russian pharmaceutical company NovaMedica, a portfolio company of RUSNANO, announces the start of construction of a plant for the production of sterile injectable drugs as part of its long-term strategy to localize innovative medicines and technologies of their development and production in Russia. The plant will be built in the industrial park “Vorsino” in the Kaluga region.

All news